Ozone Inhalation with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)- 1-butanone and/or Dibutyl Phthalate Induced Cell Cycle Alterations via Wild-type p53 Instability in B6C3F1 Mice

  • Kim, Min-Young (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Song, Kyung-Suk (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Park, Gun-Ho (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Kim, Hyun-Woo (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Park, Jin-Hong (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Kim, Jun-Sung (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Jin, Hwa (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Kook-Jong, Eu (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university) ;
  • Cho, Hyun-Sun (College of Veterinary Medicine and School of Agricultural Biotechnology, Seoul National university)
  • 발행 : 2004.03.01

초록

Changes in cell cycle control in the lungs and liver of the B6C3F1 mice (20 males per each group) exposed to ozone (0.5 ppm), 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK, 1.0 mg/kg), and dibutyl phthalate (DBP, 5,000 ppm) after 52 weeks were examined through Western, Northern blot, and immunohistochemistry based on alterations in protein expression levels of G1/S checkpoints (cyclin D1, cyclin E, and PCNA), G2/M checkpoints (cyclin B1, cyclin G, and cyclin A), negative regulators (p53, p21, GADD45, and p27), and positive regulator (mdm2). Expression levels of cyclins D1, E, G, PCNA, mutant p53, and mdm2 proteins were higher in the lungs and livers treated with combination of toxicants than in those treated with ozone only. Expression levels of the wild-type and mutant p53, p21, GADD45, p27, and mdm2 proteins and mRNAs were higher in toxicant-treated groups than those of the control. Immunohistochemical analysis revealed staining intensities of the PCNA, cyclin D1, c-myc and mdm2 protein- treated lungs and livers were stronger than those of the control group. Our results showed that combined treatment of ozone with NNK/DBP altered the cell cycle control through instability of the wild-type p53 gene. Such pivotal p53-mediated cell cycle alterations may be responsible for the toxicity observed under our experimental condition. These results may be applied to risk assessment of mixture-induced toxicity.

키워드

참고문헌

  1. Lippmann, M. (1989): Health effects of ozone: a critical review, J. Am. Pollution control Assoc., 39, 672-695
  2. Hoffmann, D. and Hecht, S.S. (1985): Nicotine-derived N-nit-rosamines and tobacco related cancer; current status and future directions, Cancer Res., 45, 935-944
  3. Hecht, S.S. and Hoffmann, D. (1989): The relevance of tobacco-specific nitrosamines to human cancer, Cancer Surv., 8, 273-294
  4. Austian, J. (1973): Toxicity and health threats of phthalate esters: review of the literature, Environ. Health Perspect., 4, 3-26
  5. Harris, C.A., Henttu, P., Parker, M.G. and Sumpter, J.P. (1997): The estrogenic activity of phthalate esters in vitro, Environ. Health Perspect., 105, 802-811
  6. Jobling, S., Reynold, T., White, R., Parker, M.G. and Sumpter, J.P. (1995): A variety of environmentally persistent chemicals, including some phthalate plasticizer, are weakly estrogenic. Environ. Health Perspect., 103, 582-587
  7. Sonnenschein, C., Soto, A.M., Fernanfez, M.F., Olea, N., Olea-Serrano, M.F. and Ruiz-Lopez, M.D. (1995): Development of a marker of estrogenic exposure in human serum, Clin. Chem., 41, 1888-1895
  8. Lee, C.C. and Fukushima, S. (1998): Alterations in cyclin D1, p53, and the cell cycle related elements: Implications for distinct genetic pathways of urinary bladder carcinogene-sis, Urol. Oncology, 4, 58-72
  9. National Toxicology Program (NTP) (1994): Toxicology and carcinogenesis studies of ozone and ozone/ NNK in F344/N rats and B6C3F1 mice (inhalation studies). NTP Technical Report No. 440. U. S. Department of Health and Human Services. Public Health Service. National Institutes of Health. Research Triangle Park. N. C. 27709
  10. National Toxicology Program (NTP) (1995): Toxicity studies of Dibutyl Phthalate administered in feed F344/N rats and B6C3F1 mice. NTP Technical Report No. 30. U. S. Department of Health and Human Services. Public Health Service. National Institutes of Health. Research Triangle Park. N. C. 27709
  11. Lewin, B. (1997): Cell cycle and growth regulation. In Lewin B editors, Genes VI, Oxford University Press, New York. U.S.A.
  12. Rocha, S., Martin, A.M., Meek, D.W. and Perkins, N.D. (2003): p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Associ-ation of the p52 NF-kappaB Subunit with Histone Deacetylase 1. Mol Cell Biol., 23, 4713-4727
  13. Kim, M.Y., Kim, Y.C. and Cho, M.H. (2002): Combined treatment with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and dibutyl phthalate enhances ozone-induced genotoxicity in B6C3F1 mice. Mutagenesis, 17, 331-336
  14. Guillouf, C., Rosselli, F., Krishnaraju, K., Moustacchi, E., Hoff-man, B. and Liebermann, D.A. (1995): p53 involvement in control of G2 exist of the cell cycle: role in DNA damage-induced apoptosis. Oncogene, 10, 2263-2270
  15. Skladanowski, A and Larsen, A. (1997): Expression of wild-type p53 increases etoposide cytotoxicity in M1 myeloid leukemia cells by facilitated G2 to M transition: implica-tions for gene therapy. Cancer Res., 57, 818-823
  16. Ohtsuka, T., Ryu, H., Minamishima, Y.A., Ryo, A. and Lee, S.W. (2003): Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Onco-gene., 22, 1678-1687
  17. Beniston, R.G. and Campo, M.S. (2003): Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 trans-formed human keratinocytes, Oncogene, 22, 5504-5514
  18. Leach, S.D., Scatena, C.D., Keefer, C.J., Goodman, H.A., Song, S.Y., Yang, L. and Pietenpol, J.A. (1998): Negative regulation of wee1 expression and cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. Can-cer Res., 58, 3231-3236
  19. Innocente, S.A., Abrahamson, J.L.A., Cogswell, J.P. and Lee, J.M. (1999): p53 regulates a G2 checkpoint through cyclin B1. Pro. Natl. Acad. Sci. USA, 96, 2147-2152
  20. Stewart, N., Hicks, G.G., Praskevas, F. and Mowat, M. (1995): Evidence for a second cell cycle block at G2/M by p53. Oncogene, 10, 109-115
  21. Masramon, L., Arribas, R. and Tortola, S. (1998): Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer. Br J Cancer, 77, 2349-2356 https://doi.org/10.1038/bjc.1998.390
  22. Waters, C.M., Littlewood, T.D., Hancock, D.C., Moore, J.P. and Evan, G.l. (1991): c-Myc protein expression in untrans-formed fibroblasts. Oncogene, 6, 797-805
  23. Hildesheim, J., Bulavin, D.V., Anver, M.R., Alvord, W.G., Hol-lander, M.C., Vardanian, L. and Fornace, A.J. Jr. (2002): Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Res., 62, 7305-7315